Ledger.Open graph →
SEC Form D · Amendment · filed April 9, 2010

Nautilus Neurosciences, Inc

Offering
$17.8M
Sold
$17.8M
Exemption
—
Industry
Pharmaceuticals
Location
BRIDGEWATER, NJ
Type
—

People & firms on this filing (14)

Robert Russell · Calgary, Alberta, CanadaDirectorNavjot Athwal · San Franciso, CADirectorBenjamin T. Sporn · Newton Center, MAExecDouglas M. Karp · New York, NYDirectorChristopher J. Risewick · Des Moines, IAExec · DirectorLawrence A. First · New York, NYDirectorWilliam Maichle · Bridgewater, NJExecDennis Folden · West Des Moines, IAExecEric J. Liebler · Bridgewater, NJExec · DirectorNeil R. Milano · Bridgewater, NJExecJames L. Fares · Bridgewater, NJExec · DirectorMatthew Q. Giffuni · Fort Lauderdale, FLDirectorSiobhan C. Foy · Walnut Creek, CADirectorJohn P. Fitzsimons · New York, NYExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗